Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: news events new research seeks understand patient perspectives hematologic cancers
Cost-Effective Second-Line ADHD Drug with Better Efficacy Reported Share on: August 25, 2016 About one-third of patients with ADHD have an inadequate response to initial stimulant treatment and consequently might be considered for treatment with one of …
… a world leader in in-vitro diagnostics, conducted research to determine the clinical and economic impact of … tests GFAP+UCH-L1 or S100B all in one analysis. The research contributes to growing evidence that the biomarker …
Webinar: Beyond Controlling for Confounding Share on: Thursday, September 27, 2018, 10 - 11am Watch the Recording Going One Step Further in Observational Studies: Design Strategies Randomized clinical trials (RCTs) are the gold standard to quantify the …
… and supplementary data (e.g., natural history studies and patient registries) when evaluating the safety and efficacy …
… to gather evidence, analyze results, and disseminate your research . We'll help you increase understanding, and provide …
… and key tips for successful projects in these easy-to-understand infographics. …
… Lynda Doward Patient-Centered Outcomes Assessment Oncology Medical … over 30 years of experience in patient-reported outcomes research. She provides advice and guidance to pharmaceutical … and validation. Ms. Doward has particular expertise in research design and in the application of both traditional …
… payer tools, value communication materials, and payer research. Dr. Ling has experience in a wide range of …
… Disorders CNS/Neurology Cardiovascular Headquarters - Research Triangle Park, North Carolina, USA PhD, Epidemiology … multidatabase studies in the United States and Europe, patient registries and site-based studies in the United … disease, and smoking cessation, as well as in the research areas of risk minimization measures and structured …
Regulatory Guidance and Support We can support you throughout your regulatory negotiations. Our team has negotiated with the FDA’s Clinical Outcome Assessments (COA) team and a wide variety of reviewing divisions on numerous occasions to select and …